IN2013MU03308A - - Google Patents

Info

Publication number
IN2013MU03308A
IN2013MU03308A IN3308MU2013A IN2013MU03308A IN 2013MU03308 A IN2013MU03308 A IN 2013MU03308A IN 3308MU2013 A IN3308MU2013 A IN 3308MU2013A IN 2013MU03308 A IN2013MU03308 A IN 2013MU03308A
Authority
IN
India
Prior art keywords
pharmaceutically acceptable
acceptable derivative
imipenem
stereoisomer
compound
Prior art date
Application number
Other languages
English (en)
Inventor
Sachin Bhagwat
Mahesh Vithalbhai Patel
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to JP2016525559A priority Critical patent/JP2016538262A/ja
Priority to AU2014338611A priority patent/AU2014338611A1/en
Priority to US15/030,310 priority patent/US9789097B2/en
Priority to RU2016115374A priority patent/RU2016115374A/ru
Priority to CN201480069849.2A priority patent/CN106132411A/zh
Priority to IN3308MU2013 priority patent/IN2013MU03308A/en
Priority to PCT/IB2014/065521 priority patent/WO2015059642A1/en
Priority to MX2016005160A priority patent/MX2016005160A/es
Priority to CA2928358A priority patent/CA2928358A1/en
Priority to EP14806073.4A priority patent/EP3060208B1/en
Publication of IN2013MU03308A publication Critical patent/IN2013MU03308A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN3308MU2013 2013-10-22 2014-10-22 IN2013MU03308A (ar)

Priority Applications (10)

Application Number Priority Date Filing Date Title
JP2016525559A JP2016538262A (ja) 2013-10-22 2014-10-22 抗菌剤を含む医薬品組成物
AU2014338611A AU2014338611A1 (en) 2013-10-22 2014-10-22 Pharmaceutical compositions comprising antibacterial agents
US15/030,310 US9789097B2 (en) 2013-10-22 2014-10-22 Pharmaceutical compositions comprising antibacterial agents
RU2016115374A RU2016115374A (ru) 2013-10-22 2014-10-22 Фармацевтические композиции, содержащие антибактериальные агенты
CN201480069849.2A CN106132411A (zh) 2013-10-22 2014-10-22 包含抗菌剂的药物组合物
IN3308MU2013 IN2013MU03308A (ar) 2013-10-22 2014-10-22
PCT/IB2014/065521 WO2015059642A1 (en) 2013-10-22 2014-10-22 Pharmaceutical compositions comprising antibacterial agents
MX2016005160A MX2016005160A (es) 2013-10-22 2014-10-22 Composiciones farmaceuticas que comprenden agentes antibacterianos.
CA2928358A CA2928358A1 (en) 2013-10-22 2014-10-22 Pharmaceutical compositions comprising antibacterial agents
EP14806073.4A EP3060208B1 (en) 2013-10-22 2014-10-22 Pharmaceutical compositions comprising antibacterial agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3308MU2013 IN2013MU03308A (ar) 2013-10-22 2014-10-22

Publications (1)

Publication Number Publication Date
IN2013MU03308A true IN2013MU03308A (ar) 2015-07-17

Family

ID=52003011

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3308MU2013 IN2013MU03308A (ar) 2013-10-22 2014-10-22

Country Status (10)

Country Link
US (1) US9789097B2 (ar)
EP (1) EP3060208B1 (ar)
JP (1) JP2016538262A (ar)
CN (1) CN106132411A (ar)
AU (1) AU2014338611A1 (ar)
CA (1) CA2928358A1 (ar)
IN (1) IN2013MU03308A (ar)
MX (1) MX2016005160A (ar)
RU (1) RU2016115374A (ar)
WO (1) WO2015059642A1 (ar)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018193368A1 (en) * 2017-04-18 2018-10-25 Wockhardt Limited Antibacterial compositions
US11905286B2 (en) 2018-08-09 2024-02-20 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101420446B1 (ko) * 2005-09-22 2014-07-16 메이지 세이카 파루마 가부시키가이샤 메탈로-β-락타마제 저해제
AU2012310136B2 (en) * 2011-09-13 2016-07-07 Wockhardt Limited Nitrogen containing compounds and their use

Also Published As

Publication number Publication date
JP2016538262A (ja) 2016-12-08
US9789097B2 (en) 2017-10-17
US20160303094A1 (en) 2016-10-20
CA2928358A1 (en) 2015-04-30
WO2015059642A1 (en) 2015-04-30
EP3060208A1 (en) 2016-08-31
EP3060208B1 (en) 2018-09-19
AU2014338611A1 (en) 2016-05-12
MX2016005160A (es) 2016-10-05
RU2016115374A3 (ar) 2018-08-15
CN106132411A (zh) 2016-11-16
RU2016115374A (ru) 2017-11-28

Similar Documents

Publication Publication Date Title
PH12018500591A1 (en) Heterocyclic compounds and uses thereof
PH12015501996A1 (en) Heterocyclic compounds and uses thereof
MX2018002986A (es) Compuestos de heteroarilo como inhibidores de cinasas asociadas al receptor de interleucina 1 (irak) y sus usos.
IN2014MN02598A (ar)
NZ739676A (en) Heteroaryl compounds as irak inhibitors and uses thereof
TN2015000519A1 (en) Small molecule inhibitors of fibrosis
MX2016013431A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
MY181641A (en) Amino pyran ring derivative and composition and use thereof
MY162886A (en) Novel tetrahydropyridopyrimidine compound or salt thereof
PH12017500459A1 (en) Azetidinyloxyphenylpyrrolidine compounds
MX2016001138A (es) Compuestos de benzoxaborol triciclico, metodo de preparacion y uso del mismo.
AU2015292632B2 (en) Aldosterone synthase inhibitors
MY180006A (en) Azetidinyloxyphenylpyrrolidine compounds
EA033423B1 (ru) Циклопропанбензофуранилпиридопиразиндионы
IN2013MU01985A (ar)
IN2013MU03308A (ar)
IN2013MU03704A (ar)
IN2013MU03422A (ar)
IN2013MU03309A (ar)
IN2014MU00859A (ar)
IN2013MU03421A (ar)
IN2013CH04314A (ar)
IN2013MU03565A (ar)
MX2016013428A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
MX2017010992A (es) Composiciones farmaceuticas estables que comprenden agente antibacteriano.